Insider Transactions in Q4 2025 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 07
2025
|
Andrew Fisher General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,349,887
-100.0%
|
-
|
|
Oct 07
2025
|
Andrew Fisher General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
931,984
+50.0%
|
-
|
|
Oct 07
2025
|
Anders Ullman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
430,856
-100.0%
|
-
|
|
Oct 07
2025
|
Anders Ullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Michael Austwick Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
84,712
-100.0%
|
-
|
|
Oct 07
2025
|
Michael Austwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Mark W Hahn Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,550,248
-100.0%
|
-
|
|
Oct 07
2025
|
Mark W Hahn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,285,280
+50.0%
|
-
|
|
Oct 07
2025
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,564,852
-100.0%
|
-
|
|
Oct 07
2025
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,131,984
+50.0%
|
-
|
|
Oct 07
2025
|
David Zaccardelli President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,461,424
-100.0%
|
-
|
|
Oct 07
2025
|
David Zaccardelli President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,285,280
+50.0%
|
-
|
|
Oct 07
2025
|
Lisa Deschamps Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
156,856
-100.0%
|
-
|
|
Oct 07
2025
|
Lisa Deschamps Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Vikas Sinha Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
166,112
-100.0%
|
-
|
|
Oct 07
2025
|
Vikas Sinha Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Mahendra Shah Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
165,472
-100.0%
|
-
|
|
Oct 07
2025
|
Mahendra Shah Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Christina Ackermann Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
136,072
-100.0%
|
-
|
|
Oct 07
2025
|
Christina Ackermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Kenneth Cunningham Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
151,776
-100.0%
|
-
|
|
Oct 07
2025
|
Kenneth Cunningham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
James Aloysius Brady Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
95,176
-100.0%
|
-
|
|
Oct 07
2025
|
James Aloysius Brady Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
Martin Edwards Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
229,992
-100.0%
|
-
|
|
Oct 07
2025
|
Martin Edwards Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|
|
Oct 07
2025
|
David R Ebsworth Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
617,600
-100.0%
|
-
|
|
Oct 07
2025
|
David R Ebsworth Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
952,499
-100.0%
|
-
|
|
Oct 07
2025
|
David R Ebsworth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+50.0%
|
-
|